VanEck Pharmaceutical ETF
PPH
PPH
86 hedge funds and large institutions have $416M invested in VanEck Pharmaceutical ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
86
Holders Change
-5
Holders Change %
-5.49%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
29
Reduced
24
Closed
13
Calls
$7.4M
Puts
$410K
Net Calls
+$6.99M
Net Calls Change
+$3.31M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$141M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$4.14M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$6.76M |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$3.48M |
| 5 |
5
LPL Financial
San Diego,
California
|
$4.89M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$7.13M |
| 2 |
2
Jane Street
New York
|
$1.45M |
| 3 |
3
M&T Bank
Buffalo,
New York
|
$0 |
| 4 |
LJAC
4
L.J. Altfest & Co
New York
|
$4.03M |
| 5 |
NL
5
NVWM LLC
Yardley,
Pennsylvania
|
$0 |
